Cumberland Pharmaceuticals Reports First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Cumberland Pharmaceuticals (CPIX) Reports Q1 EPS of $0.09
May 7, 2015 5:10 PM EDTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of $0.09, versus $0.05 reported last year. Revenue for the quarter came in at $8.7 million, versus $8.1 million reported last year.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
... More